<DOC>
	<DOCNO>NCT01986608</DOCNO>
	<brief_summary>This study conduct compare pharmacokinetics Lacosamide ( LCM ) follow single 30-minute 60-minute iv infusion LCM 200 mg follow single oral dose LCM 200 mg healthy Japanese subject .</brief_summary>
	<brief_title>Bioavailability/Bioequivalence Study Between Lacosamide Tablet Solution Infusion Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Healthy Japanese male female volunteer age 20 55 year old Subject participate participate clinical study investigational drug another investigational medical product within last 3 month Subject history ( within 6 month ) screen visit chronic alcohol and/or drug abuse and/or smoke and/or history presence cardiovascular , respiratory , hepatic , renal , GI , endocrinological , neurological disorder Subject history suicide attempt current active suicidal ideation Subject experience myocardial infarction and/or make blood donation blood loss 400 ml last 3 month Subject pregnant nursing Subject healthy ( eg , take drug treatment , medical emotional/psychological problem , drug/alcohol abuse , abnormal safety parameter and/or positive HIV , HBsAg , HCV ) Subject excessive use alcohol or/and cigarettes and/or caffeine and/or abnormal diet and/or take grapefruit grapefruit drink within 7 day intake Investigational Medicinal Product ( IMP ) Subject clinically significant abnormality 12lead Electrocardiogram ( ECG ) Subject clinically relevant drug hypersensitivity component investigational medicinal product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Vimpat</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Japanese</keyword>
</DOC>